Position in VIR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,449,629
+$55,216 QoQ
Shares Held
161,789
-30.0% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tejara Capital Ltd holds $25,474,690 across 8 Biotechnology names. VIR ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
3,495,187 | $9,891,379 | |
| 2 | HRTX |
Heron Therapeutics, Inc. /De/
|
6,336,755 | $5,069,404 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
166,191 | $3,915,459 | |
| 4 | QURE |
uniQure N.V.
|
122,092 | $1,996,204 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
210,400 | $1,689,512 | |
| 6 | VIR |
Vir Biotechnology, Inc.
This page
|
161,789 | $1,449,629 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
24,300 | $790,722 | |
| 8 | MREO |
Mereo BioPharma Group plc
|
2,037,520 | $672,381 |
All Filings in VIR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,449,629 | 161,789 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,394,413 | 231,246 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,467,121 | 256,939 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,303,344 | 258,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,488,274 | 229,672 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $381,437 | 51,967 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||